Novo Nordisk A Revenue per Employee (NVO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Novo Nordisk A  (NYSE: NVO)
 

Novo Nordisk A's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 11.14% in the fourth quarter 2025, year on year to cumulative value of $46,820 million, Novo Nordisk A's revenue per employee grew on a trailing twelve months basis to $ 673,625. The productivity of Novo Nordisk A's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 12 other companies have achieved higher revenue per employee. While Novo Nordisk A's total ranking has deteriorated compared to the previous quarter from to 314. Novo Nordisk A has 69,505 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVO Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 11.14 % - - - -
Sales per Employee (TTM) $ 673,625 606,085 606,085 606,085 606,085
NVO's Total Ranking # 314 # # # #
Seq. Revenue Change - - - - -

NVO Company Profile >> Back to NVO Efficiency Comparisons >> Compare NVO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 7
Healthcare Sector # 13
Overall Market # 314

Revenue per Employee Statistics
High Average Low
$ 4,446,644 $ 1,323,821 $ 255,115
(Dec 31 2025)   (Dec 31 2018)



Financial Statements
Novo Nordisk A's Revenue MRQ $ 46,820 Millions Visit NVO's Income Statement
Novo Nordisk A's Revenues TTM $ 46,820 Millions Visit NVO's aggregate revenue growth
What are NVO's Sales? Visit NVO's Sales by Segment




Other Ratios
Novo Nordisk A's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NVO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NVO's Competitors
Revenue per Employee for NVO's Suppliers
Revenue per Employee for NVO's Customers

You may also want to know
NVO's Sales Growth Rates NVO's Pe Price to earnings ratio NVO's Receivables Turnover Ratio NVO's Stock Quote
NVO's Net Income Growth Rates NVO's Ps Price to Sales ratio NVO's Sales per Employee NVO's Asset Turnover Ratio
NVO's Net Margin NVO's Pb Price to Book ratio NVO's Financial Strength Ratios NVO's Dividend Payout Ratio
Date modified: 2026-09-10T03:11:57+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Scynexis Inc   1,144,500.00 $ 20.601  Million 18 
Cytomx Therapeutics Inc   1,104,362.32 $ 76.201  Million 69 
Supernus Pharmaceuticals inc   1,102,687.12 $ 718.952  Million 652 
Stoke Therapeutics Inc   1,084,823.53 $ 184.420  Million 170 
Abbvie Inc   1,072,982.46 $ 61,160.000  Million 57,000 
Arvinas Inc   1,067,479.67 $ 262.600  Million 246 
Journey Medical Corp  1,066,517.24 $ 61.858  Million 58 
Arcutis Biotherapeutics Inc   1,062,350.28 $ 376.072  Million 354 
Madrigal Pharmaceuticals Inc   1,047,434.97 $ 958.403  Million 915 
Corcept Therapeutics Inc  1,043,023.29 $ 761.407  Million 730 
Integrated Biopharma Inc  1,021,360.00 $ 51.068  Million 50 
Biomarin Pharmaceutical Inc  1,000,078.55 $ 3,221.253  Million 3,221 
Coya Therapeutics Inc   993,219.13 $ 7.946  Million 8 
Assembly Biosciences Inc   990,452.05 $ 72.303  Million 73 
Travere Therapeutics Inc   987,380.28 $ 490.728  Million 497 
Hims and Hers Health Inc   961,252.25 $ 2,347.378  Million 2,442 
Sanara Medtech Inc   949,972.34 $ 102.597  Million 108 
Cue Biopharma Inc   947,103.45 $ 27.466  Million 29 
Lifevantage Corp  934,533.63 $ 208.401  Million 223 
Regeneron Pharmaceuticals Inc   930,752.76 $ 14,342.900  Million 15,410 
Ani Pharmaceuticals Inc  910,686.60 $ 883.366  Million 970 
Keenova Therapeutics Plc  906,562.50 $ 1,450.500  Million 1,600 
Scilex Holding Company  889,794.12 $ 30.253  Million 34 
Evolus Inc   889,541.92 $ 297.107  Million 334 
Day One Biopharmaceuticals Inc   888,662.92 $ 158.182  Million 178 
Xtant Medical Holdings Inc   882,602.65 $ 133.273  Million 151 
Nektar Therapeutics  876,698.41 $ 55.232  Million 63 
Pacira Biosciences inc   876,249.70 $ 726.411  Million 829 
Merck and Co Inc   866,813.33 $ 65,011.000  Million 75,000 
Carlisle Companies Incorporated  850,830.51 $ 5,019.900  Million 5,900 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.